| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/13/2005 | WO2005002643A2 Method and products for delivering biological molecules to cells using multicomponent nanostructures |
| 01/13/2005 | WO2005002594A1 An anti-tumor rna interference drug for multidrug resistance |
| 01/13/2005 | WO2005002573A2 Methods for using modulators of proline-rich tyrosine kinase 2 |
| 01/13/2005 | WO2005002512A2 Immunotherapeutic vaccine strategy |
| 01/13/2005 | WO2005002511A2 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | WO2005002509A2 Dna vectors |
| 01/13/2005 | WO2005002507A2 Modulation of survivin expression |
| 01/13/2005 | WO2005002504A2 Protection against vertical transmission of pathogenic infections |
| 01/13/2005 | WO2005002359A2 Modified starch, uses, methods for production thereof |
| 01/13/2005 | WO2005002326A2 Generation of plants with improved drought tolerance |
| 01/13/2005 | WO2005002325A2 Generation of plants with improved drought tolerance |
| 01/13/2005 | WO2004099422A3 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 01/13/2005 | WO2004099409A8 Process for extracting nucleic acid |
| 01/13/2005 | WO2004094639A3 Recombinant fel d 1 allergen |
| 01/13/2005 | WO2004085644A3 Method for producing recombinant organisms |
| 01/13/2005 | WO2004081216A8 Alcohol dehydrogenase gene of acetic acid bacterium |
| 01/13/2005 | WO2004078983A3 Enhanced amylose production in plants |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004065537A3 Expression cassette with promotors of starch synthesis 3 for the expression of nucleic acids in plant tissue containing starch |
| 01/13/2005 | WO2004063378A3 Polypeptides involved in floral development and genes encoding the same |
| 01/13/2005 | WO2004056972A3 Parallel chromosomal stacking of traits in bacteria |
| 01/13/2005 | WO2004055167A3 Alphavirus particles and methods for preparation |
| 01/13/2005 | WO2004054351A3 Generation of plants with altered oil content |
| 01/13/2005 | WO2004050017A3 Rationally designed antibodies |
| 01/13/2005 | WO2004044161A3 Expression of foreign sequences in plants using trans-activation system |
| 01/13/2005 | WO2004044135A3 Structural motifs and oligomeric compounds and their use in gene modulation |
| 01/13/2005 | WO2004044131A3 Cross-linked oligomeric compounds and their use in gene modulation |
| 01/13/2005 | WO2004031230A3 Novel mhc ii associated peptides |
| 01/13/2005 | WO2004027030A3 Efficient reduction of target rna’s by single- and double-stranded oligomeric compounds |
| 01/13/2005 | WO2004027023A3 Preservation of rna and reverse transcriptase during automated liquid handling |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2003106645A3 Antisense modulation of smrt expression |
| 01/13/2005 | WO2003106625A3 Hammerhead ribozymes |
| 01/13/2005 | WO2003097815A8 Molecular identification of aspergillus species |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003072715A8 Gasp1: a follistatin domain containing protein |
| 01/13/2005 | WO2003012067A3 Expression profile of prostate cancer |
| 01/13/2005 | WO2003008540A8 Abiotic stress responsive polynucleotides and polypeptides |
| 01/13/2005 | WO2002092001A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/13/2005 | US20050010975 expression vector comprising nucleotide sequences coding retinoblastoma protein-3 (RB-3) for use in identifying modulators which shall enhances maize growth and crop yield |
| 01/13/2005 | US20050010974 Promoters for regulation of gene expression in plant roots |
| 01/13/2005 | US20050010973 Expression vector comprising heterologous nucleotide sequences which enhance amino acid biosynthesis in plants; bioreactor; tissue engineering; for use in enhancing nutritional content of animal feeds |
| 01/13/2005 | US20050010972 Fructan biosynthetic enzymes |
| 01/13/2005 | US20050010967 Animal model comprising nucleotide sequences coding small conductance calcium-activated potassium (SK) channel protein for use in identifying modulators for treatment of behavioral disorders and nervous system disorders |
| 01/13/2005 | US20050010966 Using nuclear transplantion of somatic cell genome to transform and generate cloned non-human mammal; bioengineering; tissue engineering |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050010041 Bacterial gene and method of treating a gram negative bacterial infection |
| 01/13/2005 | US20050010037 Metalloprotease expressed in transgenic plant cells for use as additive to enhance nutrient quality of animal feeds |
| 01/13/2005 | US20050010035 Spider silk protein encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 01/13/2005 | US20050009949 Modifying a poly(3-hydroxyalkanoate) biosynthetic enzyme by an evolutionary-engineering technique; and expressing the enzyme in a host to synthesize a copolylactone, especially a 3-hydroxybutyric acid-3-hydroxyalkanolic acid copolymer, in a host. |
| 01/13/2005 | US20050009771 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 01/13/2005 | US20050009770 Use of excipients to increase DNA uptake by swine muscle cells |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009738 Interleukin with nucleic acid carrier |
| 01/13/2005 | US20050009199 Fixing protein, DNA and other biopolymers on solid support surface and quantitatively measuring the number of molecules and the density and/or concentration of molecules immobilized to support via fluorimetric imaging |
| 01/13/2005 | US20050009189 Using transgenic plants comprising enhanced very long chain fatty acid elongases (VLCFAE) as diagnostic tools in detecting modulators of plant growth; herbicides and crop protection |
| 01/13/2005 | US20050009188 Animal immunocontraceptives expressed in plants and uses thereof |
| 01/13/2005 | US20050009187 Environmental stress-responsive promoter and genes encoding transcriptional factor |
| 01/13/2005 | US20050009186 Expression vector comprising 3' and 5' long terminal repeats and preferential splice junctions for use as heterologous gene transfer tool; gene therapy |
| 01/13/2005 | US20050009185 Using replication defcetive hepadnaviral plasmid comprising nucleotide sequences coding chemokines and/or cytokines for use in the treatment of liver disorders; tissue engineering and gene therapy |
| 01/13/2005 | US20050009184 Humanised baculovirus |
| 01/13/2005 | US20050009183 Antisense modulation of hypothetical protein LOC51249 expression |
| 01/13/2005 | US20050009182 Using recombinase to mediate irreversible site-specific polynucleotide replacement in eukaryotic cells; heterologous gene expression and tissue engineering |
| 01/13/2005 | US20050009177 Telomerase interference |
| 01/13/2005 | US20050009167 Alkaline protease from Bacillus sp. (DSM 14390) and washing and cleaning products comprising said alkaline protease |
| 01/13/2005 | US20050009166 Cellulase variants |
| 01/13/2005 | US20050009165 Raffinose synthase gene, method for producing raffinose, and transgenic plant |
| 01/13/2005 | US20050009162 3-phosphoglycerate dehydrogenase variants whose inhibition by L-serine is reduced, and genes encoding them |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009149 Trimeric tumor necrosis factor receptors for use as modulator for treatment of rheumatoid arthritis, atherosclerosis, osteoporosis, allograft rejection, cancer, inflammatory bowel and autoimmune diseases |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009146 Using sequence similarity to identify potential microorganismal metalloprotease sequences; generating metalloenzymes in bacterial host for use in cleaning compounds and detergents |
| 01/13/2005 | US20050009145 Mammalian receptor proteins; related reagents and methods |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050009137 Intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/13/2005 | US20050009135 Transgenic yeast or fungi comprising nucleotide sequences coding phosphoglucomutase; for use as sources of enhanced ethanol fermentation |
| 01/13/2005 | US20050009112 Methods for identifying Rheb effectors as lead compounds for drug development for diabetes and diseases associated with abnormal cell growth |
| 01/13/2005 | US20050009108 Using 16s ribosomal RNA as diagnostic tool in detection of campylobacter DNA sequences in biological fluids; diagnosing bacterial infection |
| 01/13/2005 | US20050009107 Using hybridoma cells to generate monoclonal antibody specific to 7-transmembrane receptor protein for use in the diagnosis, prevention and treatment of psychological and nervous system disorders |
| 01/13/2005 | US20050009091 DNA and vectors having engineered recombination sites which enhance efficiency of protein mediated specific recombination events; plasmids and heterologous gene transfer and expression |
| 01/13/2005 | US20050009088 Antisense modulation of apolipoprotein B-expression |
| 01/13/2005 | US20050009087 Novel human enzymes and polynucleotides encoding the same |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009083 Vectors, cells and processes for pyrimidine deoxyribonucleosides production |
| 01/13/2005 | US20050009082 Beads, preparing method for the same, flow cytometer and program |
| 01/13/2005 | US20050009080 Using site directed mutagenesis to generate protein of preferential activity; directed protein evolution |
| 01/13/2005 | US20050009077 Composition of matter comprising library of first nucleic acid analyte copies |
| 01/13/2005 | US20050009072 Genetic testing kits and a method of bladder cancer |
| 01/13/2005 | US20050009063 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 01/13/2005 | US20050009062 Phosphodiesterase 10 |
| 01/13/2005 | US20050009061 Anther-specific genes, their promoters, and uses of the same |
| 01/13/2005 | US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/13/2005 | US20050009056 Anti-infective therapy |
| 01/13/2005 | US20050009049 Expanding the eukaryotic genetic code |
| 01/13/2005 | US20050009048 Using quantitative real-time polymerase chain reaction to determine concentration of preferential nucleotide sequences in sample: molecular diagnostics |
| 01/13/2005 | US20050009045 Contacting with cationic surfactant (cetyltrimethylammonium bromide); ribonuclease inhibitors; for sampling DNA/RNA in tissues |
| 01/13/2005 | US20050009042 Oligonucleotide seqences for controlling expression of leptin receptor gene associated protein (OB-RGRP); for treatment and prevention of bone, thrombic, sexual, blood, immunological, inflammatory and cancer disorders |